Results 181 to 190 of about 7,838 (234)

Maximizing Metabolic Synergy: A Review of Dual Incretin Therapy as a Step-Up Strategy Following Glucagon-Like Peptide-1 (GLP-1) Monotherapy Failure or Optimization. [PDF]

Cureus
Ansari Lari S, Zumot MS, Alrashid MA.
europepmc   +1 more source

Tirzepatide in recurrent hypertriglyceridemia-mediated pancreatitis and type 2 diabetes: a case report. [PDF]

Cardiovasc Diabetol Endocrinol Rep
Lechner B, Lechner K, Freibothe I, Vogt A.   +3 more
europepmc   +1 more source

Dose-Dependent Influence of RBD-Derived Amyloidogenic Peptides on SARS-CoV-2 Infectivity: A Cautionary Tale for Antiviral Design. [PDF]

Int J Mol Sci
Nikiforova MA, Grishin SY, Aksenova AY, Deryusheva EI, Likhachev IV, Fadeev RS, Kobyakova MI, Kochetov AP, Surin AK, Gushchin VA, Galzitskaya OV.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Insulin-lispro

Reactions Weekly, 2023
semanticscholar   +3 more sources

Insulin Lispro

Drugs, 2012
Donna McTavish, Michelle I Wilde, D McTavish   +2 more
exaly   +3 more sources

Insulin Lispro Update

The Diabetes Educator, 2002
PURPOSE This paper provides a review of the literature and clinical studies for insulin lispro and updated information on its advantages over regular insulin for various populations of people with diabetes. METHODS Information was gathered from a search of Medline articles and from review of ...
Jerry D, Meece, R Keith, Campbell
openaire   +2 more sources